NEW YORK, August 9, 2017 /PRNewswire/ --
If you want a Stock Review on CVS, HUM, MOH, or UNH then come over to http://dailystocktracker.com/register/
Shares in Woonsocket, Rhode Island headquartered CVS Health Corp. saw a slight drop of 0.70%, ending Tuesday's trading session at $78.57. The stock recorded a trading volume of 8.64 million shares, which was higher than its three months average volume of 5.85 million shares. The Company's shares have gained 0.55% in the last one month. The stock is trading 0.09% below its 50-day moving average. Moreover, shares of CVS Health, which together with its subsidiaries, provide integrated pharmacy health care services, have a Relative Strength Index (RSI) of 48.61.
On July 20th, 2017, CVS Health announced the opening of its Talent Connect Center to serve the Fort Bragg, NC military community. This innovative employment and training facility will be dedicated to helping veterans and their families' transition from military life to private sector civilian careers. Visit us today and access your complete report on CVS for free at: http://dailystocktracker.com/registration/?symbol=CVS Humana
Louisville, Kentucky headquartered Humana Inc.'s stock rose 0.24%, closing the day at $250.22 with a total trading volume of 1.26 million shares. The Company's shares have advanced 4.68% in the past month, 8.51% in the previous three months, and 22.64% since the start of this year. The stock is trading 5.99% and 16.98% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Humana, which together with its subsidiaries, operates as a health and well-being company in the US, have an RSI of 69.96.
On July 12th, 2017, Humana and Oscar Health, a consumer-focused, technology-driven insurance startup based in New York, announced a strategic partnership to offer commercial health insurance to small businesses in a nine-county Nashville, Tenn. area. The announcement follows the recent launch of Oscar for Business, the US's first technology-driven health insurance for employers in April 2017. The new plans will be available this fall, pending regulatory approval. The complimentary research report on HUM can be accessed at: http://dailystocktracker.com/registration/?symbol=HUM
On Tuesday, shares in Long Beach, California headquartered Molina Healthcare Inc. recorded a trading volume of 1.50 million shares, which was above their three months average volume of 1.10 million shares. The stock ended the day 0.02% higher at $58.60. The Company's shares have advanced 8.00% since the start of this year, and are trading above their 200-day moving average by 1.66%. Furthermore, shares of Molina Healthcare, which provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the US, have an RSI of 19.33.
On August 03rd, 2017, Molina Healthcare reported its financial results for Q2 2017. Net loss per diluted share was $4.10 in Q2 2017 compared with net income per diluted share of $0.58 reported for Q2 2016. Loss before income tax benefit for the quarter was $314 million. Register for free on DailyStockTracker.com and download the research report on MOH at: http://dailystocktracker.com/registration/?symbol=MOH
Minnetonka, Minnesota-based UnitedHealth Group Inc.'s stock gained 0.06%, finishing yesterday's session at $194.90 with a total trading volume of 1.73 million shares. The Company's shares have advanced 4.25% in the last one month, 12.50% in the previous three months, and 21.78% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 4.90% and 16.12%, respectively. Additionally, shares of UnitedHealth Group, which operates as a diversified health and well-being company in the US, have an RSI of 70.63.
On July 19th , 2017, research firm Mizuho reiterated its 'Buy' rating on the Company's stock with an increase of the target price from $200 a share to $235 a share.
On August 07th, 2017, UnitedHealth Group's Board of Directors of announced that Valerie Montgomery Rice, M.D. and Sir Andrew Witty have joined the board. Montgomery Rice is the President and Dean of the Morehouse School of Medicine, a medical school in Atlanta, Georgia, and has served in that capacity since 2014 and as the EVP and Dean from 2011 to 2014. Witty was CEO and a board member of GlaxoSmithKline PLC, a global pharmaceutical company, from 2008 to April 2017. Get free access to your research report on UNH at: http://dailystocktracker.com/registration/?symbol=UNH
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://dailystocktracker.com/disclaimer/
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
A prosthetic heart valve is an artificial device surgically implanted into the heart to replace a ...
PUVA or photochemotherapy is used to treat several skin disorders with the help of UV light and the ...
Breathing in unclean air due to increasing air pollution could cause kidney damage with resultant ...View All